Scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into ‘cold’ tumors and flip on an immune response that has been turned off by cancer. The research offers new findings that could help improve therapies for glioblastoma and other aggressive cancers that are difficult to treat.